|
Jul 3
|
Biopharmaceuticals Manufacturing Consumables Testing Market 2025-2030: Thermo Fisher Scientific, Danaher Corporation, and Merck Lead
|
|
Jul 2
|
Jim Cramer on Thermo Fisher: “It Does Seem Like it’s Bottoming”
|
|
Jul 1
|
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
|
|
Jun 30
|
Is Danaher's M&A Premium Already Priced In?
|
|
Jun 30
|
Danaher appoints Martin Stumpe as chief technology and AI officer
|
|
Jun 28
|
Jim Cramer on Danaher: “This Stock Has Been Such a Disappointment for Me”
|
|
Jun 27
|
CVS vs. DHR: Which Stock Is the Better Value Option?
|
|
Jun 27
|
Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences
|
|
Jun 27
|
1 Industrials Stock for Long-Term Investors and 2 to Ignore
|
|
Jun 25
|
Opus Water Launches -- Serving the Water, Wastewater and Industrial Process Fluids Industries
|
|
Jun 25
|
Danaher Corporation (DHR) Is “Fool’s Gold,” Bemoans Jim Cramer
|
|
Jun 25
|
Oligonucleotide Synthesis Market Research and Global Forecast Report 2025-2030: Rising Emphasis on Advancing Drug Delivery and Scalable Synthesis Technologies for Oligonucleotide-Based Therapeutics
|
|
Jun 25
|
Fortive Corporation (FTV) Is A “Great” Company, Says Jim Cramer
|
|
Jun 24
|
Danaher Corporation (DHR): A Bull Case Theory
|
|
Jun 20
|
Why Danaher (DHR) is a Top Growth Stock for the Long-Term
|
|
Jun 17
|
Danaher Schedules Second Quarter 2025 Earnings Conference Call
|
|
Jun 17
|
Q1 Earnings Highlights: Agilent (NYSE:A) Vs The Rest Of The Research Tools & Consumables Stocks
|
|
Jun 13
|
Top Analyst Reports for Eli Lilly, Home Depot & SAP
|
|
Jun 12
|
3 of Wall Street’s Favorite Stocks Skating on Thin Ice
|
|
Jun 11
|
CVS vs. DHR: Which Stock Should Value Investors Buy Now?
|